Drug Report History #260413
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v6-FR | Version v4-FR |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-02-10 (Updated) | 2025-10-20 |
| Drug Identification Number | 02329050 | 02329050 |
| Brand name | SEHCAT | SEHCAT |
| Common or Proper name | Tauroselcholic Acid | Tauroselcholic Acid |
| Company Name | GE HEALTHCARE CANADA INC | GE HEALTHCARE CANADA INC |
| Ingredients | TAUROSELCHOLIC ACID | TAUROSELCHOLIC ACID |
| Strength(s) | 370KBq | 370KBq |
| Dosage form(s) | CAPSULE | CAPSULE |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 1 capsule | 1 capsule |
| Anatomical Therapeutical Chemical (ATC) code | V09DX | V09DX |
| Anatomical Therapeutical Chemical (ATC) description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2026-04-14 (Updated) | 2026-06-24 |
| Actual start date | ||
| Estimated end date | 2026-12-31 | 2026-12-31 |
| Actual end date | ||
| Shortage status | Anticipated shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | To register a new drug substance manufacturer and drug product manufacturer | To register a new drug substance manufacturer and drug product manufacturer |
| Health Canada comments |